Abstract
Ototoxicity is the general term for drug-induced damage to the cochlea or the vestibular system resulting in hearing and balance deficits, respectively. The anticancer agent cisplatin and the aminoglycoside antibiotics represent the clinically most relevant ototoxins. Understanding the molecular mechanisms of their toxic side effects is important not only from a basic science point of view but also to pave the way for protective treatment and the development of less toxic pharmaceuticals. In vivo studies will remain the gold standard of ototoxicity research because an assessment of auditory function (“hearing”) and balance is only possible in the intact animal. Nevertheless, several in vitro systems have been proposed and successfully used for probing mechanisms and pharmacological interventions. We describe here the morphology and physiology of the inner ear and evaluate the strengths and weaknesses of the most widely used model systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurootol 5(1):3–22
Rizzi MD, Hirose K (2007) Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 15(5):352–357
Fee WE Jr (1980) Aminoglycoside ototoxicity in the human. Laryngoscope 90((10 Pt 2 Suppl 24)):1–19
Moore RD, Smith CR, Lietman PS (1984) Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. J Infect Dis 149(1):23–30
Lerner SA, Schmitt BA, Seligsohn R, Matz GJ (1986) Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Am J Med 80(6B):98–104
Fausti SA, Henry JA, Schaffer HI, Olson DJ, Frey RH, McDonald WJ (1992) High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity. J Infect Dis 165(6):1026–1032
Duggal P, Sarkar M (2007) Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC Ear Nose Throat Disord 7:5
Benedetti Panici P, Greggi S, Scambia G, Baiocchi G, Lomonaco M, Conti G, Mancuso S (1993) Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up. Int J Gynecol Cancer 3(1): 44–53
Schacht J, Talaska AE, Rybak LP (2012) Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) 295(11):1837–1850
Einar-Jon E, Trausti O, Asgeir H, Christian M, Thomas W, Mans M, Jon K, Hannes P (2011) Hearing impairment after platinum-based chemotherapy in childhood. Pediatr Blood Cancer 56(4):631–637
Einarsson EJ, Petersen H, Wiebe T, Fransson PA, Grenner J, Magnusson M, Moell C (2010) Long term hearing degeneration after platinum-based chemotherapy in childhood. Int J Audiol 49(10):765–771
Dallos P, Popper AN, Fay RR (1996) The cochlea, vol 8, vol IV, Springer handbook of auditory research. Springer, New York
Wangemann P (2006) Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J Physiol 576(Pt 1): 11–21
Von Békésy G (1960) Experiments in hearing. R. E. Krieger, New York
Sellick PM, Patuzzi R, Johnstone BM (1982) Measurement of basilar membrane motion in the guinea pig using the Mossbauer technique. J Acoust Soc Am 72(1):131–141
Fettiplace R, Hackney CM (2006) The sensory and motor roles of auditory hair cells. Nat Rev Neurosci 7(1):19–29
Day BL, Fitzpatrick RC (2005) The vestibular system. Curr Biol 15(15):R583–R586
Ding D, Allman BL, Salvi R (2012) Review: ototoxic characteristics of platinum antitumor drugs. Anat Rec (Hoboken) 295(11): 1851–1867
Matz GJ (1993) Aminoglycoside cochlear ototoxicity. Otolaryngol Clin North Am 26(5):705–712
Hawkins JE Jr, Stebbins WC, Johnsson LG, Moody DB, Muraski A (1977) The patas monkey as a model for dihydrostreptomycin ototoxicity. Acta Otolaryngol 83(1–2):123–129
Stebbins WC, Moody DB, Hawkins JE Jr, Johnsson LG, Norat MA (1987) The species-specific nature of the ototoxicity of dihydrostreptomycin in the patas monkey. Neurotoxicology 8(1):33–44
Stebbins WC, Miller JM, Johnsson LG, Hawkins JE Jr (1969) Ototoxic hearing loss and cochlear pathology in the monkey. Ann Otol Rhinol Laryngol 78(5):1007–1025
Tran Ba Huy P, Bernard P, Schacht J (1986) Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest 77(5):1492–1500
Li H, Steyger PS (2011) Systemic aminoglycosides are trafficked via endolymph into cochlear hair cells. Sci Rep 1:159
Dulon D, Hiel H, Aurousseau C, Erre JP, Aran JM (1993) Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence. C R Acad Sci III 316(7):682–687
Alharazneh A, Luk L, Huth M, Monfared A, Steyger PS, Cheng AG, Ricci AJ (2011) Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity. PLoS One 6(7):e22347
Imamura S, Adams JC (2003) Distribution of gentamicin in the guinea pig inner ear after local or systemic application. J Assoc Res Otolaryngol 4(2):176–195
Sha SH, Taylor R, Forge A, Schacht J (2001) Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 155(1–2):1–8
Hawkins E Jr (1973) Ototoxic mechanisms. A working hypothesis. Audiology 12(5): 383–393
Ruedi L, Furrer W, Luthy F, Nager G, Tschirren B (1952) Further observations concerning the toxic effects of streptomycin and quinine on the auditory organ of guinea pigs. Laryngoscope 62(4):333–351
Sone M, Schachern PA, Paparella MM (1998) Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity. Hear Res 115(1–2):217–223
Lindeman HH (1969) Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol 67(2):177–189
Black FO, Pesznecker SC (1993) Vestibular ototoxicity. Clinical considerations. Otolaryngol Clin North Am 26(5):713–736
Taguchi T, Nazneen A, Abid MR, Razzaque MS (2005) Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 148:107–121
Hinojosa R, Riggs LC, Strauss M, Matz GJ (1995) Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 16(6):731–740
Poirrier AL, Van den Ackerveken P, Kim TS, Vandenbosch R, Nguyen L, Lefebvre PP, Malgrange B (2010) Ototoxic drugs: difference in sensitivity between mice and guinea pigs. Toxicol Lett 193(1):41–49
Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76(6):386–394
Klis SF, O’Leary SJ, Hamers FP, De Groot JC, Smoorenburg GF (2000) Reversible cisplatin ototoxicity in the albino guinea pig. Neuroreport 11(3):623–626
Yorgason JG, Fayad JN, Kalinec F (2006) Understanding drug ototoxicity: molecular insights for prevention and clinical management. Expert Opin Drug Saf 5(3):383–399
Yorgason JG, Kalinec GM, Luxford WM, Warren FM, Kalinec F (2010) Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: evidence from two parallel in vitro mouse models. Otolaryngol Head Neck Surg 142(6):814–819, 819.e1–819.e2
Rybak LP, Ramkumar V (2007) Ototoxicity. Kidney Int 72(8):931–935
Rybak LP, Mukherjea D, Jajoo S, Kaur T, Ramkumar V (2012) siRNA-mediated knock-down of NOX3: therapy for hearing loss? Cell Mol Life Sci 69(14):2429–2434
Kaur T, Mukherjea D, Sheehan K, Jajoo S, Rybak LP, Ramkumar V (2011) Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation. Cell Death Dis 2:e180
Schacht J, Hawkins JE (2006) Sketches of otohistory. Part 11: ototoxicity: drug-induced hearing loss. Audiol Neurootol 11(1):1–6
Lue AJ, Brownell WE (1999) Salicylate induced changes in outer hair cell lateral wall stiffness. Hear Res 135(1–2):163–168
Shehata WE, Brownell WE, Dieler R (1991) Effects of salicylate on shape, electromotility and membrane characteristics of isolated outer hair cells from guinea pig cochlea. Acta Otolaryngol 111(4):707–718
Dieler R, Shehata-Dieler WE, Brownell WE (1991) Concomitant salicylate-induced alterations of outer hair cell subsurface cisternae and electromotility. J Neurocytol 20(8): 637–653
Tuzel IH (1981) Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol 21(11–12 Pt 2):615–619
West BA, Brummett RE, Himes DL (1973) Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch Otolaryngol 98(1):32–37
Taylor RR, Nevill G, Forge A (2008) Rapid hair cell loss: a mouse model for cochlear lesions. J Assoc Res Otolaryngol 9(1):44–64
Heffner RS (2004) Primate hearing from a mammalian perspective. Anat Rec A: Discov Mol Cell Evol Biol 281(1):1111–1122
Stebbins WC, Clark WW, Pearson RD, Weiland NG (1973) Noise- and drug-induced hearing loss in monkeys. Adv Otorhinolaryngol 20:42–63
Shepherd RK, Xu SA, Clark GM (1994) Partial hearing loss in the macaque following the co-administration of kanamycin and ethacrynic acid. Hear Res 72(1–2):89–98
Carey JP, Cooper T, Jallo GI, Carson BS, Guarnieri M (2005) Ototoxicity of carboplatin delivered locally in a monkey brainstem. Int J Toxicol 24(6):443–449
Henry KR, Chole RA, McGinn MD, Frush DP (1981) Increased ototoxicity in both young and old mice. Arch Otolaryngol 107(2):92–95
Wu WJ, Sha SH, McLaren JD, Kawamoto K, Raphael Y, Schacht J (2001) Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear Res 158(1–2):165–178
Mount RJ, Takeno S, Wake M, Harrison RV (1995) Carboplatin ototoxicity in the chinchilla: lesions of the vestibular sensory epithelium. Acta Otolaryngol Suppl 519:60–65
Wake M, Takeno S, Ibrahim D, Harrison R, Mount R (1993) Carboplatin ototoxicity: an animal model. J Laryngol Otol 107(7): 585–589
Lautermann J, Song B, McLaren J, Schacht J (1995) Diet is a risk factor in cisplatin ototoxicity. Hear Res 88(1–2):47–53
Lautermann J, McLaren J, Schacht J (1995) Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res 86(1–2):15–24
Fischer FP, Gleich O, Köppl C, Manley GA (2000) Comparative anatomy and physiology of hearing organs. In: Manley GA (ed) Auditory worlds: sensory analysis and perception in animals and man, 1st edn. WILEY, Weinheim
Gleich O, Manley GA (2000) Comparative hearing: birds and reptiles. In: Dooling RJ, Fay RR, Popper AN (eds) Comparative hearing: birds and reptiles, Volume 13. Springer handbook of auditory research. Springer, New York
Frenz DA, Yoo H, Liu W (1998) Basilar papilla explants: a model to study hair cell regeneration-repair and protection. Acta Otolaryngol 118(5):651–659
Slattery EL, Warchol ME (2010) Cisplatin ototoxicity blocks sensory regeneration in the avian inner ear. J Neurosci 30(9):3473–3481
Flock A (1964) Electron microscopic and electrophysiological studies on the lateral line canal organ. Acta Otolaryngol Suppl 199:1–90
Wersaell J, Flock A (1964) Suppression and restoration of the microphonic output from the lateral line organ after local application of streptomycin. Life Sci 3:1151–1155
Kaus S (1992) The influence of calcium on the ototoxicity of aminoglycosides. Acta Otolaryngol 112(1):83–87
Ou HC, Santos F, Raible DW, Simon JA, Rubel EW (2010) Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. Drug Discov Today 15(7–8):265–271
Williams JA, Holder N (2000) Cell turnover in neuromasts of zebrafish larvae. Hear Res 143(1–2):171–181
Ou HC, Raible DW, Rubel EW (2007) Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line. Hear Res 233(1–2): 46–53
Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC (2008) Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 9(2):178–190
Brand Y, Setz C, Levano S, Listyo A, Chavez E, Pak K, Sung M, Radojevic V, Ryan AF, Bodmer D (2011) Simvastatin protects auditory hair cells from gentamicin-induced toxicity and activates Akt signaling in vitro. BMC Neurosci 12:114
Ou HC, Cunningham LL, Francis SP, Brandon CS, Simon JA, Raible DW, Rubel EW (2009) Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle. J Assoc Res Otolaryngol 10(2):191–203
Owens KN, Santos F, Roberts B, Linbo T, Coffin AB, Knisely AJ, Simon JA, Rubel EW, Raible DW (2008) Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet 4(2):e1000020
Matt T, Ng CL, Lang K, Sha SH, Akbergenov R, Shcherbakov D, Meyer M, Duscha S, Xie J, Dubbaka SR, Perez-Fernandez D, Vasella A, Ramakrishnan V, Schacht J, Bottger EC (2012) Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci U S A 109(27): 10984–10989
Karasawa T, Wang Q, Fu Y, Cohen DM, Steyger PS (2008) TRPV4 enhances the cellular uptake of aminoglycoside antibiotics. J Cell Sci 121(Pt 17):2871–2879
Chen FQ, Hill K, Guan YJ, Schacht J, Sha SH (2012) Activation of apoptotic pathways in the absence of cell death in an inner-ear immortomouse cell line. Hear Res 284(1–2): 33–41
Dinh C, Bas E, Dinh J, Vu L, Gupta C, Van De Water TR (2013) Short interfering RNA against bax attenuates TNFalpha-induced ototoxicity in rat organ of Corti explants. Otolaryngol Head Neck Surg 148(5): 834–840
Lindl T, Gstraunthaler G (2008) Zell- und Gewebekultur. Von den Grundlagen zur Laborbank, 6th edn. Springer, Heidelberg
Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, Kioussis D (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A 88(12):5096–5100
Rivolta MN, Holley MC (2002) Cell lines in inner ear research. J Neurobiol 53(2): 306–318
Kalinec F, Kalinec G, Boukhvalova M, Kachar B (1999) Establishment and characterization of conditionally immortalized organ of corti cell lines. Cell Biol Int 23(3):175–184
Rivolta MN, Grix N, Lawlor P, Ashmore JF, Jagger DJ, Holley MC (1998) Auditory hair cell precursors immortalized from the mammalian inner ear. Proc Biol Sci 265(1406):1595–1603
Lawlor P, Marcotti W, Rivolta MN, Kros CJ, Holley MC (1999) Differentiation of mammalian vestibular hair cells from conditionally immortal, postnatal supporting cells. J Neurosci 19(21):9445–9458
Kalinec GM, Webster P, Lim DJ, Kalinec F (2003) A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol 8(4):177–189
Previati M, Lanzoni I, Astolfi L, Fagioli F, Vecchiati G, Pagnoni A, Martini A, Capitani S (2007) Cisplatin cytotoxicity in organ of Corti-derived immortalized cells. J Cell Biochem 101(5):1185–1197
Bertolaso L, Martini A, Bindini D, Lanzoni I, Parmeggiani A, Vitali C, Kalinec G, Kalinec F, Capitani S, Previati M (2001) Apoptosis in the OC-k3 immortalized cell line treated with different agents. Audiology 40(6): 327–335
Cederroth CR (2012) Loss of aminoglycoside sensitivity in HEI-OC1 cells? Hear Res 292(1–2):83–85, author response pg 6
Forge A, Li L (2000) Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res 139(1–2):97–115
Cunningham LL, Cheng AG, Rubel EW (2002) Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 22(19):8532–8540
Jiang H, Sha SH, Schacht J (2005) NF-kappaB pathway protects cochlear hair cells from aminoglycoside-induced ototoxicity. J Neurosci Res 79(5):644–651
Mammano F, Ashmore JF (1996) Differential expression of outer hair cell potassium currents in the isolated cochlea of the guinea-pig. J Physiol 496(Pt 3):639–646
Leitner MG, Halaszovich CR, Oliver D (2011) Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate. Mol Pharmacol 79(1):51–60
Myrdal SE, Johnson KC, Steyger PS (2005) Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear Res 204(1–2):156–169
Winburn IC, Gunatunga K, McKernan RD, Walker RJ, Sammut IA, Harrison JC (2012) Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications. Basic Clin Pharmacol Toxicol 111(1):31–41
Schaechinger TJ, Oliver D (2007) Nonmammalian orthologs of prestin (SLC26A5) are electrogenic divalent/chloride anion exchangers. Proc Natl Acad Sci U S A 104(18):7693–7698
Lewinska A, Wnuk M, Slota E, Bartosz G (2007) Total anti-oxidant capacity of cell culture media. Clin Exp Pharmacol Physiol 34(8):781–786
Sha SH, Chen FQ, Schacht J (2009) Activation of cell death pathways in the inner ear of the aging CBA/J mouse. Hear Res 254(1–2):92–99
Sha SH, Kanicki A, Dootz G, Talaska AE, Halsey K, Dolan D, Altschuler R, Schacht J (2008) Age-related auditory pathology in the CBA/J mouse. Hear Res 243(1–2):87–94
Jiang H, Sha SH, Schacht J (2006) Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics. J Neurosci Res 83(8):1544–1551
Zhao H, Avenarius MR, Gillespie PG (2012) Improved biolistic transfection of hair cells. PLoS One 7(10):e46765
Belyantseva IA (2009) Helios gene gun-mediated transfection of the inner ear sensory epithelium. Methods Mol Biol 493: 103–123
Gubbels SP, Woessner DW, Mitchell JC, Ricci AJ, Brigande JV (2008) Functional auditory hair cells produced in the mammalian cochlea by in utero gene transfer. Nature 455(7212): 537–541
Zheng JL, Gao WQ (2000) Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci 3(6):580–586
Driver EC, Kelley MW (2010) Transfection of mouse cochlear explants by electroporation. Curr Protoc Neurosci Chapter 4:Unit 4.34.1–10
Holt JR (2002) Viral-mediated gene transfer to study the molecular physiology of the Mammalian inner ear. Audiol Neurootol 7(3):157–160
Luebke AE, Rova C, Von Doersten PG, Poulsen DJ (2009) Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies. Adv Otorhinolaryngol 66:87–98
Zheng G, Zhu K, Wei J, Jin Z, Duan M (2011) Adeno-associated viral vector-mediated expression of NT4-ADNF-9 fusion gene protects against aminoglycoside-induced auditory hair cell loss in vitro. Acta Otolaryngol 131(2):136–141
Acknowledgments
Photos in Figs. 2 and 3 by courtesy of Gao Wei, M.D., Kresge Hearing Research Institute. The authors thank Bettina U. Wilke and Murielle Kluge for their help with the illustrations and for careful reading of the manuscript. This work was supported by research grant 17/2013 MR of the University Medical Center Giessen and Marburg (UKGM) to M.G.L. J.S’s research on ototoxins is supported by grant DC 003685 from the National Institute for Deafness and Communication Disorders, National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Schacht, J., Leitner, M.G. (2014). In Vitro Models for Ototoxic Research. In: Bal-Price, A., Jennings, P. (eds) In Vitro Toxicology Systems. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0521-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0521-8_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0520-1
Online ISBN: 978-1-4939-0521-8
eBook Packages: Springer Protocols